You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 3451 to 3475 of about 5975
Next 25
01/09/2009
Medication Errors Among Adults and Children With Cancer in the Outpatient Setting.
01/07/2009
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma.
01/05/2009
Musella Foundation awards brain tumor research grant!
Fundraiser in NYC to benefit the brain tumor center at Duke!
Salk researchers create brain cancer mouse model
01/03/2009
CD offers `Hope` to patients
12/31/2008
Fatigue in low-grade glioma
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results.
Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival.
Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma.
National Brain Tumor Society - Regional Conference in San Francisco, CA
Short Delay in Initiation of Radiotherapy May Not Affect Outcome of Patients With Glioblastoma: A Secondary Analysis From the Radiation Therapy Oncology Group Database.
The story of human cytomegalovirus and cancer: increasing evidence and open questions.
12/25/2008
ImmunoCellular Therapeutics’ Cancer Vaccine Demonstrates Immune Response against Brain Cancer in Clinical Trial
12/19/2008
Open-Label Bites Drug Duo
M. D. Anderson neurosurgeon, Amy Heimberger, M.D., receives presidential award
12/18/2008
Watch Good Morning America Friday Morning!
12/16/2008
Country star will rock Asbury Park for brain cancer research benefit
12/15/2008
Brain tumor cluster
IBTA Newsletter
12/14/2008
An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma
12/11/2008
21st Century Brain Surgery: Minimally Invasive Endonasal Approach, Experienced Surgeons Give Patients the Advantages They Need
12/10/2008
Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme.